The Latest Breaking News from FDA

With rising global medical requirements and continuous technological advancements, the healthcare industry is poised to remain buoyed in the near term. Therefore, quality medical stocks Abbott Laboratories (ABT) and Varex Imaging (VREX) might be solid buys before January ends. However, avoiding fundamentally weak stock SmileDirectClub (SDC) could be wise. Read…

The new approach would simplify vaccination guidance so that, every fall, people would get a new shot, updated to try to match whatever variant is dominant.

"We are committed to working with the FDA to ensure the fastest possible path to bring this potential medicine to patients in need," Eli Lilly said.

Stock futures mixed with Fed talk, earnings in focus; Netflix surges as blowout subscriber gains offset earnings miss; Costco shares gain as bulk retail unveils $4 billion buyback plan; Nordstrom slumps after slashing profit forecast following weak holiday sales and Eli Lilly slides as FDA rejects fast track review of…

Another potential legal setback for the FDA's attempt to regulate electronic cigarettes as tobacco products.

At-home rapid tests have become a staple of COVID-19 precautions, but some experts worry that people are relying too much on these tests and that's creating a false sense of security.

Researchers claim frequent exposure to the devices causes cell mutations similar to those observed in skin cancer patients

Law enforcement can potentially use this data to prosecute people who end their pregnancies with medication

The Food and Drug Administration has filed a lawsuit accusing a Boca Raton pharmaceutical manufacturer of selling “adulterated” drugs and failure to correct violations cited by the FDA in 2018.